A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

The long-term costs of traumatic stress: intertwined physical and psychological consequences

(2015) ALEXANDER C. McFARLANE   World Psychiatry

A meta-analysis of the association between posttraumatic stress disorder and suicidality: the role of comorbid depression

(2012) Maria Panagioti et al.   COMPREHENSIVE PSYCHIATRY

The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

(2011) C M Hysek et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

(2010) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale

(2009) PØ Johansen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of MDMA on sociability and neural response to social threat and social reward

(2009) Gillinder Bedi et al.   PSYCHOPHARMACOLOGY

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

(2009) G. J. H. Dumont et al.   Social Neuroscience

Social Bonds and Posttraumatic Stress Disorder

(2007) Anthony Charuvastra et al.   Annual Review of Psychology